{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-063785","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2024-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.649541+00:00","generated_at":"2026-06-05T00:41:46.580337+00:00","sec_items":["7.01","9.01"],"event_type":"dividend","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Graphite Bio declares special $1.03/share dividend tied to Lenz merger","bullets":["Special dividend estimated at $1.03 per share, capped at $60M.","Record date March 18, 2024; payment date March 21, 2024.","Dividend contingent on closing of merger with Lenz Therapeutics.","Graphite stockholders vote on merger at special meeting March 14, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-063785","json":"https://secwatch.observer/filing/0001193125-24-063785.json","markdown":"https://secwatch.observer/filing/0001193125-24-063785.md","text":"https://secwatch.observer/filing/0001193125-24-063785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000119312524063785/0001193125-24-063785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000119312524063785/d784350d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T00:41:46.580337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}